-
Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020
- Marzia Lazzerini1 , Idanna Sforzi2 , Sandra Trapani3 , Paolo Biban4 , Davide Silvagni4 , Giovanna Villa5 , Jessica Tibaldi5 , Luca Bertacca6 , Enrico Felici7 , Giuseppina Perricone7 , Roberta Parrino8 , Claudia Gioè9 , Sara Lega1 , Mariasole Conte1 , Federico Marchetti10 , Annamaria Magista11 , Paola Berlese12 , Stefano Martelossi12 , Francesca Vaienti13 , Enrico Valletta13 , Margherita Mauro14 , Roberto Dall’Amico14 , Silvia Fasoli15 , Antonio Gatto16 , Antonio Chiaretti16 , Danica Dragovic17 , Paola Pascolo17 , Chiara Pilotto18 , Ilaria Liguoro18 , Elisabetta Miorin19 , Francesca Saretta19 , Gian Luca Trobia20 , Antonella Di Stefano20 , Azzurra Orlandi21 , Fabio Cardinale21 , Riccardo Lubrano22 , Alessia Testa22 , Marco Binotti23 , Valentina Moressa1 , Egidio Barbi1,24 , Benedetta Armocida1 , Ilaria Mariani1 , on behalf of COVID-19 Italian Pediatric Study Network25
-
View Affiliations Hide AffiliationsAffiliations: 1 Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, Trieste, Italy 2 Department of Pediatric Emergency Medicine and Trauma Center, Meyer Children's University Hospital, Florence, Italy 3 Department of Health Sciences and Meyer Children's University Hospital, Florence, Italy 4 Department of Neonatal and Paediatric Critical Care, Verona University Hospital, Verona Italy 5 Pediatric Emergency Unit, IRCCS Gaslini Children's Hospital, Genoa, Italy 6 Pediatric Emergency Unit and Department of Pediatric and Neonatology, Misericordia Hospital, Grosseto, Italy 7 Pediatric and Pediatric Emergency Unit, The Children Hospital, AO SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy 8 Pediatria d'Urgenza e Pronto Soccorso P.O.G. Di Cristina, Palermo, Italy 9 Pediatric Infectious diseases, P.O.G. Di Cristina, Palermo, Italy 10 Department of Pediatrics, Ravenna Hospital, Ravenna, Italy 11 Department of Pediatrics, Community Pediatrics, Ravenna, Italy 12 Department of Pediatrics, Treviso Hospital, Treviso, Italy 13 Department of Pediatrics, G.B. Morgagni-L. Pierantoni Hospital, Forlì, Italy 14 Department of Pediatrics and Neonatology, Santa Maria degli Angeli Hospital, Pordenone, Italy 15 Paediatric Unit, Carlo Poma Hospital, Mantua, Italy 16 Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy 17 Department of Pediatrics, San Polo Hospital, ASUGI, Monfalcone (GO), Italy 18 Division of Paediatrics, Department of Medicine DAME, Academic Hospital Santa Maria della Misericordia, University of Udine, Udine, Italy 19 Department of Pediatrics, Latisana-Palmanova, ASUFC, Udine, Italy 20 Pediatric and Pediatric Emergency Room Unit Cannizzaro Emergency Hospital, Catania, Italy 21 Giovanni XXIII Pediatric Hospital, Department of Pediatrics, University of Bari, Bari, Italy 22 Department of Pediatrics Sapienza University of Rome, Santa Maria Goretti Hospital, Latina, Italy 23 Neonatal and Pediatric Intensive Care Unit, Maggiore della Carità University Hospital, Novara, Italy 24 University of Trieste, Trieste, Italy 25 Members of the COVID-19 Italian Pediatric Study Network are acknowledged at the end of the articleMarzia Lazzerinimarzia.lazzerini burlo.trieste.it
-
View Citation Hide Citation
Citation style for this article: Lazzerini Marzia, Sforzi Idanna, Trapani Sandra, Biban Paolo, Silvagni Davide, Villa Giovanna, Tibaldi Jessica, Bertacca Luca, Felici Enrico, Perricone Giuseppina, Parrino Roberta, Gioè Claudia, Lega Sara, Conte Mariasole, Marchetti Federico, Magista Annamaria, Berlese Paola, Martelossi Stefano, Vaienti Francesca, Valletta Enrico, Mauro Margherita, Dall’Amico Roberto, Fasoli Silvia, Gatto Antonio, Chiaretti Antonio, Dragovic Danica, Pascolo Paola, Pilotto Chiara, Liguoro Ilaria, Miorin Elisabetta, Saretta Francesca, Trobia Gian Luca, Di Stefano Antonella, Orlandi Azzurra, Cardinale Fabio, Lubrano Riccardo, Testa Alessia, Binotti Marco, Moressa Valentina, Barbi Egidio, Armocida Benedetta, Mariani Ilaria, on behalf of COVID-19 Italian Pediatric Study Network. Characteristics and risk factors for SARS-CoV-2 in children tested in the early phase of the pandemic: a cross-sectional study, Italy, 23 February to 24 May 2020. Euro Surveill. 2021;26(14):pii=2001248. https://doi.org/10.2807/1560-7917.ES.2021.26.14.2001248 Received: 19 Jun 2020; Accepted: 19 Nov 2020
- Previous Article
- Table of Contents
- Next Article
Abstract
Very few studies describe factors associated with COVID-19 diagnosis in children.
We here describe characteristics and risk factors for COVID-19 diagnosis in children tested in 20 paediatric centres across Italy.
We included cases aged 0–18 years tested between 23 February and 24 May 2020. Our primary analysis focused on children tested because of symptoms/signs suggestive of COVID-19.
Among 2,494 children tested, 2,148 (86.1%) had symptoms suggestive of COVID-19. Clinical presentation of confirmed COVID-19 cases included besides fever (82.4%) and respiratory signs or symptoms (60.4%) also gastrointestinal (18.2%), neurological (18.9%), cutaneous (3.8%) and other unspecific influenza-like presentations (17.8%). In multivariate analysis, factors significantly associated with SARS-CoV-2 positivity were: exposure history (adjusted odds ratio (AOR): 39.83; 95% confidence interval (CI): 17.52–90.55; p < 0.0001), cardiac disease (AOR: 3.10; 95% CI: 1.19–5.02; p < 0.0001), fever (AOR: 3.05%; 95% CI: 1.67–5.58; p = 0.0003) and anosmia/ageusia (AOR: 4.08; 95% CI: 1.69–9.84; p = 0.002). Among 190 (7.6%) children positive for SARS-CoV-2, only four (2.1%) required respiratory support and two (1.1%) were admitted to intensive care; all recovered.
Recommendations for SARS-CoV-2 testing in children should consider the evidence of broader clinical features. Exposure history, fever and anosmia/ageusia are strong risk factors in children for positive SARS-CoV-2 testing, while other symptoms did not help discriminate positive from negative individuals. This study confirms that COVID-19 was a mild disease in the general paediatric population in Italy. Further studies are needed to understand risk, clinical spectrum and outcomes of COVID-19 in children with pre-existing conditions.
Article metrics loading...
Full text loading...
References
-
World Health Organization (WHO). Coronavirus disease (COVID-2019) situation reports 11. Geneva: WHO; 31 January 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4
-
Ministero della Salute. Covid-19 - Situazione in Italia. [COVID-19. Situation in Italy]. Rome: Ministero della Salute. [Accessed: 28 May 2020]. Italian. Available from: http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioContenutiNuovoCoronavirus.jsp?lingua=italiano&id=5351&area=nuovoCoronavirus&menu=vuoto
-
Ministero della Salute. COVID-19, i casi in Italia 24 maggio 2020. Aggiornamento nazionale 24 maggio 2020. [COVID-19, the cases in Italy on 24 May 2020. National update 24 May 2020]. Rome: Ministero della Salute. [Accessed: 29 Sep 2020]. Italian. Available from: http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4807
-
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020.145(6):e20200702. https://doi.org/10.1542/peds.2020-0702
-
Parri N, Magistà AM, Marchetti F, Cantoni B, Arrighini A, Romanengo M, et al. Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks. Eur J Pediatr. 2020;179(8):1315-23. https://doi.org/10.1007/s00431-020-03683-8 PMID: 32495147
-
Garazzino S, Montagnani C, Donà D, Meini A, Felici E, Vergine G, et al. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Euro Surveill. 2020;25(18):2000600. https://doi.org/10.2807/1560-7917.ES.2020.25.18.2000600 PMID: 32400362
-
Tagarro A, Epalza C, Santos M, Sanz-Santaeufemia FJ, Otheo E, Moraleda C, et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatr. 2020. https://doi.org/10.1001/jamapediatrics.2020.1346 PMID: 32267485
-
Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, et al. Epidemiology, clinical features, and disease severity in patients with coronavirus disease 2019 (COVID-19) in a children’s hospital in New York City, New York. JAMA Pediatr. 2020;174(10):e202430. https://doi.org/10.1001/jamapediatrics.2020.2430 PMID: 32492092
-
Götzinger F, Santiago-García B, Noguera-Julián A, Lanaspa M, Lancella L, Calò Carducci FI, et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. 2020;4(9):653-61. https://doi.org/10.1016/S2352-4642(20)30177-2 PMID: 32593339
-
Bialek S, Gierke R, Hughes M, McNamara LA, Pilishvili T, Skoff T, et al. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-6. https://doi.org/10.15585/mmwr.mm6914e4 PMID: 32271728
-
Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020;174(9):882-9. https://doi.org/10.1001/jamapediatrics.2020.1467 PMID: 32320004
-
Hoang A, Chorath K, Moreira A, Evans M, Burmeister-Morton F, Burmeister F, et al. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine. 2020;24:100433. https://doi.org/10.1016/j.eclinm.2020.100433 PMID: 32766542
-
Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355-68. https://doi.org/10.1097/INF.0000000000002660 PMID: 32310621
-
Mustafa NM, A Selim L. Characterisation of COVID-19 pandemic in paediatric age group: a systematic review and meta-analysis. J Clin Virol. 2020;128:104395. https://doi.org/10.1016/j.jcv.2020.104395 PMID: 32417675
-
Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088-95. https://doi.org/10.1111/apa.15270 PMID: 32202343
-
Liguoro I, Pilotto C, Bonanni M, Ferrari ME, Pusiol A, Nocerino A, et al. SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179(7):1029-46. https://doi.org/10.1007/s00431-020-03684-7 PMID: 32424745
-
Yoon S, Li H, Lee KH, Hong SH, Kim D, Im H, et al. Clinical characteristics of asymptomatic and symptomatic pediatric coronavirus disease 2019 (COVID-19): a systematic review. Medicina (Kaunas). 2020;56(9):E474. https://doi.org/10.3390/medicina56090474 PMID: 32942705
-
de Lusignan S, Dorward J, Correa A, Jones N, Akinyemi O, Amirthalingam G, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis. 2020;20(9):1034-42. https://doi.org/10.1016/S1473-3099(20)30371-6 PMID: 32422204
-
Mao B, Liu Y, Chai YH, Jin XY, Lu HW, Yang JW, et al. Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study. Lancet Digit Health. 2020;2(6):e323-30. https://doi.org/10.1016/S2589-7500(20)30109-6 PMID: 32501440
-
Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal. BMJ. 2020;369:m1328. https://doi.org/10.1136/bmj.m1328 PMID: 32265220
-
Ho FK, Celis-Morales CA, Gray SR, Vittal Katikireddi S, Niedzwiedz CL, Hastie C, et al. Modifiable and non-modifiable risk factors for COVID-19: results from UK Biobank; medRxiv 2020. https://doi.org/10.1101/2020.04.28.20083295
-
Peng D, Zhang J, Xu Y, Liu Z, Wu P. The role of procalcitonin in early differential diagnosis of suspected children with COVID-19; medRxiv 2020. https://doi.org/10.1101/2020.04.07.20057315
-
Alizadehsani R, Alizadeh Sani Z, Behjati M, Roshanzamir Z, Hussain S, Abedini N, et al. Risk factors prediction, clinical outcomes, and mortality in COVID-19 patients. J Med Virol. 2021;93(4):2307-20. https://doi.org/10.1002/jmv.26699 PMID: 33247599
-
Hobbs CV, Martin LM, Kim SS, Kirmse BM, Haynie L, McGraw S, et al. Factors associated with positive SARS-CoV-2 test results in outpatient health facilities and emergency departments among children and adolescents aged <18 years - Mississippi, September-November 2020. MMWR Morb Mortal Wkly Rep. 2020;69(50):1925-9. https://doi.org/10.15585/mmwr.mm6950e3 PMID: 33332298
-
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-7. https://doi.org/10.1016/S0140-6736(07)61602-X PMID: 18064739
-
Ministero della Salute. COVID-19. Aggiornamentodella definizione di caso. [COVID-19. Case definition update]. Rome: Ministero della Salute; Mar 2020. Italian. Available from: http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2020&codLeg=73669&parte=1%20&serie=null
-
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771-8. https://doi.org/10.1016/S0140-6736(20)31103-X PMID: 32410760
-
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212-3. https://doi.org/10.1111/jdv.16387 PMID: 32215952
-
Tullie L, Ford K, Bisharat M, Watson T, Thakkar H, Mullassery D, et al. Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children. Lancet Child Adolesc Health. 2020;4(7):e19-20. https://doi.org/10.1016/S2352-4642(20)30165-6 PMID: 32442420
-
Whittaker A, Anson M, Harky A. Neurological Manifestations of COVID-19: A systematic review and current update. Acta Neurol Scand. 2020;142(1):14-22. https://doi.org/10.1111/ane.13266 PMID: 32412088
-
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611-27. https://doi.org/10.1016/S2215-0366(20)30203-0 PMID: 32437679
-
World Health Organization (WHO). WHO COVID-19: case definitions: updated in public health surveillance for COVID-19, published 16 December 2020. Geneva: WHO; 2020. License: CC BY-NC-SA 3.0 IGO. Available from: https://apps.who.int/iris/handle/10665/337834
-
Chow EJ, Schwartz NG, Tobolowsky FA, Zacks RLT, Huntington-Frazier M, Reddy SC, et al. Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington. JAMA. 2020;323(20):2087-9. https://doi.org/10.1001/jama.2020.6637 PMID: 32301962
-
World Health Organization (WHO). Global surveillance for COVID-19 caused by human infection with COVID-19 virus. Interim guidance, 20 March 2020. License: CC BY-NC-SA 3.0 IGO. Geneva: WHO; 2020. Available from: https://apps.who.int/iris/handle/10665/331506
-
Istituto superiore di Sanità (ISS). Epidemia COVID-19. Aggiornamento nazionale 20 maggio 2020. [COVID-19 epidemic. National update 20 May 2020]. Rome: ISS; 2020. Italian. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_20-maggio-2020.pdf
-
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. https://doi.org/10.1001/jama.2020.2648 PMID: 32091533
-
Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174(9):868-73. https://doi.org/10.1001/jamapediatrics.2020.1948 PMID: 32392288
-
Centers for Disease Control and Prevention (CDC). Weekly updates by select demographic and geographic characteristics. Provisional death counts for coronavirus disease 2019 (COVID-19). Atlanta: CDC. [Accessed: 10 Jun 2020]. Available from: https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm#AgeAndSex
-
Centers for Disease Control and Prevention (CDC). Weekly U.S. influenza surveillance report. Atlanta: CDC. [Accessed: 10 Jun 2020]. Available from: https://www.cdc.gov/flu/weekly/#S3
-
Burn E, You SC, Sena AG, Kostka K, Abedtash H, Abrahão MTF, et al. An international characterisation of patients hospitalised with COVID-19 and a comparison with those previously hospitalised with influenza; medRxiv. 2020. https://doi.org/http://dx.doi.org/10.1101/2020.04.22.20074336
-
Turner D, Huang Y, Martín-de-Carpi J, Aloi M, Focht G, Kang B, et al. Corona virus disease 2019 and paediatric inflammatory bowel diseases: global experience and provisional guidance (march 2020) from the paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2020;70(6):727-33. https://doi.org/10.1097/MPG.0000000000002729 PMID: 32443020
-
Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in children with cancer in New York City. JAMA Oncol. 2020;6(9):1459-60. https://doi.org/10.1001/jamaoncol.2020.2028 PMID: 32401276
-
Hains DS, Schwaderer AL, Carroll AE, Starr MC, Wilson AC, Amanat F, et al. Asymptomatic seroconversion of immunoglobulins to SARS-CoV-2 in a pediatric dialysis unit. JAMA. 2020;323(23):2424-5. https://doi.org/10.1001/jama.2020.8438 PMID: 32407440
-
Marlais M, Wlodkowski T, Vivarelli M, Pape L, Tönshoff B, Schaefer F, et al. The severity of COVID-19 in children on immunosuppressive medication. Lancet Child Adolesc Health. 2020;4(7):e17-8. https://doi.org/10.1016/S2352-4642(20)30145-0 PMID: 32411815
-
Istituto Superiore di Sanità (ISS). Epidemia COVID-19. Aggiornamento nazionale (appendice): 20 maggio 2020. [COVID-19 epidemic. National update (appendix): 20 May 2020]. Rome: ISS; May 2020. Italian. Available from: https://www.epicentro.iss.it/coronavirus/bollettino/Bolletino-sorveglianza-integrata-COVID-19_20-maggio-2020_appendix.pdf
-
GIMBE. Coronavirus: la giungla dei tamponi In alcune regioni test con il contagocce per paura di nuovi lockdown? [Coronavirus: the jungle of swabs. In some regions very few tests performed for fear of new lockdowns?]. Bologna: Fondazione GIMBE; 7 May 2020. Italian. Available from: https://www.gimbe.org/pagine/341/it/comunicati-stampa?pagina=19
-
Godlee Fiona. Covid-19: Testing testing. BMJ. 2020;369:m1918.
-
Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323(18):1843-4. https://doi.org/10.1001/jama.2020.3786 PMID: 32159775
Data & Media loading...
Supplementary data
-
-
Supplement
-